6G6-22878-09674
2 vaccinations
6 coded responses
25 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 236 / VA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
-
2021-04-17
Dose 2 — Pfizer-BioNTech
-
2021-04-17
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, DiarrheaAdult check-in
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Heart palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Heart palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Good · Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: Heart palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-23
-
2021-04-24
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
-
2021-05-31
Survey response — day 42, dose 2MedDRA: Cough, Fatigue, Respiratory tract congestion, Wheezing — Feeling: FairFree text: Constant fatigue. Congestion that worsens in the evening, even causing some wheezing, and a persistent dry, unproductive coughing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-17
Survey response — 3 months, dose 2MedDRA: Alopecia, Confusional state, Decreased appetite, Dizziness, Fatigue, Glossitis, Headache, Hypoaesthesia, Irritability, Lymphadenopathy, Paraesthesia, Sinus congestion, Tinnitus, Tongue disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Excessive fatigue, frequent headaches, dizziness, confusion, irritability, congested sinuses, swollen glands, ringing in ears, texture of tongue is different (smooth, thick), both numbness & tingling of skin in limbs, hair falling out, no appetite.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-17
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-25
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-17
-
2022-04-21
Survey response — 12 months, dose 2MedDRA: Fatigue, Office visit, Weight increased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Significant weight gain (+20 lbs) and chronic fatigue. · Healthcare visit (other): Regular GP visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Heart palpitations
Systemic reaction (other): Heart palpitations
Systemic reaction (other): Heart palpitations
Release 8 — day 42, dose 2
Symptoms: Constant fatigue. Congestion that worsens in the evening, even causing some wheezing, and a persistent dry, unproductive coughing.
Release 9 — 3 months, dose 2
Symptoms: Excessive fatigue, frequent headaches, dizziness, confusion, irritability, congested sinuses, swollen glands, ringing in ears, texture of tongue is different (smooth, thick), both numbness & tingling of skin in limbs, hair falling out, no appetite. cut off by CDC
Release 11 — 12 months, dose 2
Symptoms: Significant weight gain (+20 lbs) and chronic fatigue.
Healthcare visit (other): Regular GP visits
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | Confusional state | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Glossitis | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Tongue disorder | · | · | ✓ |
| SD | Weight increased | · | · | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release